Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene and betamethasone dipropionate) in ...
Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...
Novavax, Inc. , a global company advancing protein-based vaccines with its novel Matrix-Mtm adjuvant, today announced that the Company granted a non- qualified stock option and restricted stock units ...
Chronic Lower Back Pain (CLBP) market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis ...
Endo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential ...
Q3 2024 Earnings Call Transcript November 6, 2024 UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.55, ...
Sukuru had technical oversight of more than a dozen contract development and manufacturing organizations worldwide while working at Endo Pharma. In his current role at Catalent, he works with hundreds ...
Sukuru had technical oversight of more than a dozen contract development and manufacturing organizations worldwide while working at Endo Pharma. In his current role at Catalent, he works with hundreds ...
China: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback